Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.

by Kate Yandell

Healthy Habits

Could a diet that leads to inflammation increase the risk of developing colorectal cancer?

by Lindsey Konkel

Healthy Habits

Exercise is associated with benefits, even for those who fall short of recommended amounts.

by Jane C. Hu

Forward Look

Talking to doctors about cancer and its treatment often means being bombarded with numbers, from percentages to risk ratios. Yet many people don’t fully comprehend what the numbers mean. As a result, cancer patients may not understand their prognosis, the effect a treatment might have, or their risk for recurrence. Photo © iStock / PeterHermesFurian To […]

by Cameron Walker

Forward Look

Q&A with molecular biologist James DeGregori on cancer development.

by Sue Rochman

Forward Look

Breast cancer risk factor may be overlooked.

by Kendall K. Morgan

The AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.

by Garrett M. Brodeur

The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.

Researchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.

by Kate Yandell

From the Editor-in-Chief

Patients should have access to this vital and emerging medical specialty.

by William G. Nelson, MD, PhD